Â¥
8.82
May 31
New Key Statistics Module, Z-Score and F-Score
SHSE:600513 Key Ratios
Market Cap ¥ M | 2,517.72 |
Enterprise Value ¥ M | 3,005.39 |
P/E(ttm) | 18.97 |
PE Ratio without NRI | 18.45 |
Forward PE Ratio | -- |
Price/Book | 1.81 |
Price/Sales | 1.13 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.31 |
Revenue (TTM) ¥ M | 2,250.00 |
EPS (TTM) ¥ | 0.47 |
Beneish M-Score | -2.4 |
10-y EBITDA Growth Rate % | 10.20 |
5-y EBITDA Growth Rate % | 18.90 |
y-y EBITDA Growth Rate % | -3.50 |
EV-to-EBIT | 14.35 |
EV-to-EBITDA | 14.35 |
PEG | 0.98 |
Shares Outstanding M | 285.46 |
Net Margin (%) | 6.06 |
Operating Margin % | 9.21 |
Pre-tax Margin (%) | 8.00 |
Quick Ratio | 0.85 |
Current Ratio | 1.10 |
ROA % (ttm) | 4.89 |
ROE % (ttm) | 10.29 |
ROIC % (ttm) | 7.83 |
Dividend Yield % | 1.72 |
Altman Z-Score | 2.67 |
SHSE:600513 Number of Guru Trades
SHSE:600513 Volume of Guru Trades
Gurus Latest Trades with SHSE:600513
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600513 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jiangsu Lianhuan Pharmaceutical Co Ltd Insider Transactions
No Available Data